Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000455427 | SCV000538323 | uncertain significance | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Only 1 paper (lower freq in cases than controls); ExAC: 13/66698 European |
Labcorp Genetics |
RCV001837901 | SCV000659304 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Robarts Research Institute, |
RCV000660701 | SCV000782886 | uncertain significance | Hypercholesterolemia, familial, 1 | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000985342 | SCV001133427 | uncertain significance | not provided | 2018-12-11 | criteria provided, single submitter | clinical testing | In the published literature, this variant has been reported in individuals suspected of being affected with familial hypercholesterolemia (PMIDs: 24503134 (2014), 32770674 (2020), 35913489 (2022)) or affected with a cardiomyopathy (PMID: 32009526 (2020)). The frequency of this variant in the general population, 0.00057 (29/50706 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant. |
Illumina Laboratory Services, |
RCV001142145 | SCV001302555 | uncertain significance | Familial hypobetalipoproteinemia 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001142146 | SCV001302556 | uncertain significance | Hypercholesterolemia, autosomal dominant, type B | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000660701 | SCV001433156 | uncertain significance | Hypercholesterolemia, familial, 1 | 2019-04-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000985342 | SCV001874940 | uncertain significance | not provided | 2022-06-06 | criteria provided, single submitter | clinical testing | Identified in a patient with dyslipidemia (Johansen et al., 2014) and in a control individual (Beaudoin et al., 2012) in published literature; In silico analysis supports that this missense variant does not alter protein structure/function; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 402376; ClinVar); This variant is associated with the following publications: (PMID: 24503134, 22923420, 27535533) |
Ambry Genetics | RCV002411423 | SCV002675512 | likely benign | Cardiovascular phenotype | 2022-09-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000985342 | SCV003799479 | uncertain significance | not provided | 2022-09-20 | criteria provided, single submitter | clinical testing | The APOB c.8550T>G; p.Ile2850Met variant (rs148498577) is reported in the literature in an individual with suspected monogenic dyslipidemia (Johansen 2014). This variant is also reported in ClinVar (Variation ID: 402376) and is found in the general population with an allele frequency of 0.017% (48/282,426 alleles) in the Genome Aggregation Database. The isoleucine at codon 2850 is moderately conserved, but computational analyses predict that this variant is neutral (REVEL: 0.037). However, given the lack of clinical and functional data, the significance of the p.Ile2850Met variant is uncertain at this time. References: Johansen CT et al. LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias. J Lipid Res. 2014 Apr;55(4):765-72. PMID: 24503134. |
Ce |
RCV000985342 | SCV004183718 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | APOB: BP4 |
Clinical Genetics, |
RCV000455427 | SCV001921323 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000985342 | SCV001965122 | likely benign | not provided | no assertion criteria provided | clinical testing |